Home » Newsletters » BioWorld Science

BioWorld Science

May 15, 2020

View Archived Issues

Liver-specific pre-eclampsia treatment is maternal-specific

Novadip reports interim data from phase I/II bone non-union study of NVD-003

Advaxis reports positive preliminary data from ongoing phase I/II study of ADXS-503 in NSCLC

Abivax receives clearance to initiate phase IIb/III study of ABX-464 COVID-19 patients

FDA approves IND application for SMP-100 as treatment of IBS

Krystal Biotech announces positive interim data from phase I/II study of KB-105

Kaleido initiates developmental program of KB-109 in mild to moderate COVID-19

SHR-170008 immunotherapy demonstrates antitumor efficacy in vivo

Pharmacodynamic and safety data presented for emixustat

Researchers identify AMRC-835 for MBL-positive Gram-negative bacterial infections

Phase II/III data support potential of rAAV2-ND4 gene therapy in patients with LHON

Daiichi Sankyo, Sanford Burnham Prebys patent AP-TNAP inhibitors

Taiho Pharmaceutical discloses mutant GTPase KRAS inhibitors

New factor XIa and/or kallikrein B inhibitors identified at Merck & Co.

Bristol-Myers Squibb discovers Toll-like receptor antagonists

New kappa opioid receptor agonists synthesized at Nippon Chemiphar

Doubling down on edits keeps type 1 diabetes in check

EGFR identified as a target in some retinoblastoma tumors

MCo-PG1 shows good efficacy in Pseudomonas aeruginosa-driven sepsis model

European Commission approves Adcetris for previously untreated sALCL

Enzychem cleared to begin Korean phase II study with EC-18 to prevent ARDS in COVID-19

Danish study to evaluate iloprost in COVID-19 patients with ARDS

FDA accepts IND for iNKT therapy agenT-797 for cancer

Lyfaquin approved in India for hypovolemic shock

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...